Cargando…

Comparison of survival between adolescent and young adult vs older patients with hepatocellular carcinoma

BACKGROUND: Due to the special clinical features and biologic characteristics of adolescent and young adult (AYA) cancers, AYA cancers are different from cancers in children and elderly individuals. However, there are few reports on AYA hepatocellular carcinoma (HCC). AIM: To investigate the overall...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Jie, Tong, Ying-Mu, Cui, Rui-Xia, Wang, Zi, Li, Qing-Lin, Liu, Wei, Qu, Kai, Zhang, Jing-Yao, Liu, Chang, Wan, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739151/
https://www.ncbi.nlm.nih.gov/pubmed/33362910
http://dx.doi.org/10.4251/wjgo.v12.i12.1394
_version_ 1783623272033681408
author Ren, Jie
Tong, Ying-Mu
Cui, Rui-Xia
Wang, Zi
Li, Qing-Lin
Liu, Wei
Qu, Kai
Zhang, Jing-Yao
Liu, Chang
Wan, Yong
author_facet Ren, Jie
Tong, Ying-Mu
Cui, Rui-Xia
Wang, Zi
Li, Qing-Lin
Liu, Wei
Qu, Kai
Zhang, Jing-Yao
Liu, Chang
Wan, Yong
author_sort Ren, Jie
collection PubMed
description BACKGROUND: Due to the special clinical features and biologic characteristics of adolescent and young adult (AYA) cancers, AYA cancers are different from cancers in children and elderly individuals. However, there are few reports on AYA hepatocellular carcinoma (HCC). AIM: To investigate the overall survival (OS) of AYA (15-39 years) and elderly (40-74 years) patients with HCC. METHODS: The data of all the HCC cases were extracted from the Surveillance, Epidemiology, and End Results database from 2004 to 2015 and were then divided into two groups based on age: AYA group (15-39 years) and older group (40-74 years). Kaplan-Meier curves and log-rank tests were used to compare the OS of the two groups. Propensity score matching (PSM) was employed to analyze the OS difference between the two groups. The Cox proportional hazards regression model was used to perform multivariate analysis to explore the risk factors for OS of HCC patients. RESULTS: Compared to elderly cancer patients, AYA patients with HCC had a worse Surveillance, Epidemiology, and End Results stage, including the distant stage (22.1% vs 15.4%, P < 0.001), and a more advanced American Joint Committee on Cancer (AJCC) stage, including AJCC III and IV (49.2% vs 38.3%, P < 0.001), and were more likely to receive surgery (64.5% vs 47.5%, P < 0.001). Before PSM, the AYA group had a longer survival in months (median: 20.00, interquartile range [IQR]: 5.00-62.50) than the older group (median: 15.00, IQR: 4.00-40.00) (P < 0.001). After PSM, the AYA group still had a longer survival in months (median: 21.00, IQR: 5.00-64.50) than the older group (median: 18.00, IQR: 6.00-53.00) (P < 0.001). The Cox proportional hazards regression model showed that advanced age (hazard ratio [HR] = 1.405, 95%CI: 1.218-1.621, P < 0.001) was a risk factor for OS of HCC patients. In the subgroup analysis, the Cox proportional hazards regression model showed that in AJCC I/II HCC patients, advanced age (HR = 1.749, 95%CI: 1.352-2.263, P < 0.001) was a risk factor for OS, while it was not a risk factor in AJCC III/IV HCC patients (HR = 1.186, 95%CI: 0.997-1.410, P = 0.054) before PSM. After PSM, advanced age (HR = 1.891, 95%CI: 1.356-2.637, P < 0.001) was still a risk factor for OS in AJCC I/II HCC patients, but was not a risk factor for OS in AJCC III/IV HCC patients (HR = 1.192, 95%CI: 0.934-1.521, P = 0.157) after PSM. CONCLUSION: AYA patients with HCC have different clinical characteristics from older adults. In different AJCC stages, the two groups of patients have different OS: In AJCC I/II HCC patients, advanced age is a risk factor for OS, but it is not a risk factor for OS in the AJCC III/IV HCC patient group.
format Online
Article
Text
id pubmed-7739151
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-77391512020-12-24 Comparison of survival between adolescent and young adult vs older patients with hepatocellular carcinoma Ren, Jie Tong, Ying-Mu Cui, Rui-Xia Wang, Zi Li, Qing-Lin Liu, Wei Qu, Kai Zhang, Jing-Yao Liu, Chang Wan, Yong World J Gastrointest Oncol Retrospective Cohort Study BACKGROUND: Due to the special clinical features and biologic characteristics of adolescent and young adult (AYA) cancers, AYA cancers are different from cancers in children and elderly individuals. However, there are few reports on AYA hepatocellular carcinoma (HCC). AIM: To investigate the overall survival (OS) of AYA (15-39 years) and elderly (40-74 years) patients with HCC. METHODS: The data of all the HCC cases were extracted from the Surveillance, Epidemiology, and End Results database from 2004 to 2015 and were then divided into two groups based on age: AYA group (15-39 years) and older group (40-74 years). Kaplan-Meier curves and log-rank tests were used to compare the OS of the two groups. Propensity score matching (PSM) was employed to analyze the OS difference between the two groups. The Cox proportional hazards regression model was used to perform multivariate analysis to explore the risk factors for OS of HCC patients. RESULTS: Compared to elderly cancer patients, AYA patients with HCC had a worse Surveillance, Epidemiology, and End Results stage, including the distant stage (22.1% vs 15.4%, P < 0.001), and a more advanced American Joint Committee on Cancer (AJCC) stage, including AJCC III and IV (49.2% vs 38.3%, P < 0.001), and were more likely to receive surgery (64.5% vs 47.5%, P < 0.001). Before PSM, the AYA group had a longer survival in months (median: 20.00, interquartile range [IQR]: 5.00-62.50) than the older group (median: 15.00, IQR: 4.00-40.00) (P < 0.001). After PSM, the AYA group still had a longer survival in months (median: 21.00, IQR: 5.00-64.50) than the older group (median: 18.00, IQR: 6.00-53.00) (P < 0.001). The Cox proportional hazards regression model showed that advanced age (hazard ratio [HR] = 1.405, 95%CI: 1.218-1.621, P < 0.001) was a risk factor for OS of HCC patients. In the subgroup analysis, the Cox proportional hazards regression model showed that in AJCC I/II HCC patients, advanced age (HR = 1.749, 95%CI: 1.352-2.263, P < 0.001) was a risk factor for OS, while it was not a risk factor in AJCC III/IV HCC patients (HR = 1.186, 95%CI: 0.997-1.410, P = 0.054) before PSM. After PSM, advanced age (HR = 1.891, 95%CI: 1.356-2.637, P < 0.001) was still a risk factor for OS in AJCC I/II HCC patients, but was not a risk factor for OS in AJCC III/IV HCC patients (HR = 1.192, 95%CI: 0.934-1.521, P = 0.157) after PSM. CONCLUSION: AYA patients with HCC have different clinical characteristics from older adults. In different AJCC stages, the two groups of patients have different OS: In AJCC I/II HCC patients, advanced age is a risk factor for OS, but it is not a risk factor for OS in the AJCC III/IV HCC patient group. Baishideng Publishing Group Inc 2020-12-15 2020-12-15 /pmc/articles/PMC7739151/ /pubmed/33362910 http://dx.doi.org/10.4251/wjgo.v12.i12.1394 Text en ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Retrospective Cohort Study
Ren, Jie
Tong, Ying-Mu
Cui, Rui-Xia
Wang, Zi
Li, Qing-Lin
Liu, Wei
Qu, Kai
Zhang, Jing-Yao
Liu, Chang
Wan, Yong
Comparison of survival between adolescent and young adult vs older patients with hepatocellular carcinoma
title Comparison of survival between adolescent and young adult vs older patients with hepatocellular carcinoma
title_full Comparison of survival between adolescent and young adult vs older patients with hepatocellular carcinoma
title_fullStr Comparison of survival between adolescent and young adult vs older patients with hepatocellular carcinoma
title_full_unstemmed Comparison of survival between adolescent and young adult vs older patients with hepatocellular carcinoma
title_short Comparison of survival between adolescent and young adult vs older patients with hepatocellular carcinoma
title_sort comparison of survival between adolescent and young adult vs older patients with hepatocellular carcinoma
topic Retrospective Cohort Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739151/
https://www.ncbi.nlm.nih.gov/pubmed/33362910
http://dx.doi.org/10.4251/wjgo.v12.i12.1394
work_keys_str_mv AT renjie comparisonofsurvivalbetweenadolescentandyoungadultvsolderpatientswithhepatocellularcarcinoma
AT tongyingmu comparisonofsurvivalbetweenadolescentandyoungadultvsolderpatientswithhepatocellularcarcinoma
AT cuiruixia comparisonofsurvivalbetweenadolescentandyoungadultvsolderpatientswithhepatocellularcarcinoma
AT wangzi comparisonofsurvivalbetweenadolescentandyoungadultvsolderpatientswithhepatocellularcarcinoma
AT liqinglin comparisonofsurvivalbetweenadolescentandyoungadultvsolderpatientswithhepatocellularcarcinoma
AT liuwei comparisonofsurvivalbetweenadolescentandyoungadultvsolderpatientswithhepatocellularcarcinoma
AT qukai comparisonofsurvivalbetweenadolescentandyoungadultvsolderpatientswithhepatocellularcarcinoma
AT zhangjingyao comparisonofsurvivalbetweenadolescentandyoungadultvsolderpatientswithhepatocellularcarcinoma
AT liuchang comparisonofsurvivalbetweenadolescentandyoungadultvsolderpatientswithhepatocellularcarcinoma
AT wanyong comparisonofsurvivalbetweenadolescentandyoungadultvsolderpatientswithhepatocellularcarcinoma